Viromed Medical AG receives high six-figure funding from German Federal Ministry for cold plasma technology development, including PulmoPlas® for respiratory infectionsViromed Medical AG receives high six-figure funding from German Federal Ministry for cold plasma technology development, including PulmoPlas® for respiratory infections

Viromed Medical AG Secures Federal Funding for Cold Plasma Medical Device Development

2026/03/24 05:08
2 min read
For feedback or concerns regarding this content, please contact us at [email protected]

Viromed Medical AG has received funding approval from Germany’s Federal Ministry of Research, Technology and Space for research and development projects in cold plasma technology. The certification was granted under the Research Allowance Act (FZulG) and comprises funding in the high six-figure euro range, marking a substantial investment in medical innovation.

The funding focuses on developing innovative medical systems for cold atmospheric plasma application, including a stationary system for integration into ventilation processes called PulmoPlas®. This technology aims to selectively inactivate pathogenic germs in the lower respiratory tract, potentially enabling new therapeutic approaches in intensive care medicine. Additionally, the development of a mobile device for contact-free plasma application to support wound healing, known as ViroCap®, is being funded through this initiative.

Both projects address key medical challenges and expand the current state of the art in medical technology. The application of cold plasma in the lungs represents a particularly novel approach for which no comparable systems currently exist, according to the company. This funding underscores Viromed’s innovative capabilities and confirms the scientific and technological relevance of its solutions in the medical field.

With this financial support, Viromed is advancing the development of both PulmoPlas® and ViroCap® systems, strengthening its position in non-pharmacological treatment of infectious diseases. The company, which has been listed on the stock exchange since October 2022, focuses on distributing innovative cold plasma technology for medical applications through its wholly owned subsidiary Viromed Medical GmbH. More information about the company can be found at https://www.viromed-medical-ag.de.

The funding represents a significant step toward realizing the growth potential of cold plasma technology in medicine. By developing these specialized systems, Viromed aims to provide healthcare professionals with new tools to combat infections and improve patient outcomes through advanced technological solutions that operate without traditional pharmaceuticals.

Blockchain Registration, Verification & Enhancement provided by NewsRamp™

This news story relied on content distributed by NewMediaWire. Blockchain Registration, Verification & Enhancement provided by NewsRamp™. The source URL for this press release is Viromed Medical AG Secures Federal Funding for Cold Plasma Medical Device Development.

The post Viromed Medical AG Secures Federal Funding for Cold Plasma Medical Device Development appeared first on citybuzz.

Market Opportunity
SIX Logo
SIX Price(SIX)
$0.00879
$0.00879$0.00879
-0.90%
USD
SIX (SIX) Live Price Chart
Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact [email protected] for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

BTC supply on centralized exchanges is at a 7-year low

BTC supply on centralized exchanges is at a 7-year low

PANews reported on September 18th that crypto analyst The DeFi Investor wrote on the X platform: "The supply of BTC on centralized exchanges is at its lowest level in seven years. The scale of funds invested by institutions in purchasing Bitcoin in this cycle is incredible."
Share
PANews2025/09/18 09:53
Breaking: CME Group Unveils Solana and XRP Options

Breaking: CME Group Unveils Solana and XRP Options

CME Group launches Solana and XRP options, expanding crypto offerings. SEC delays Solana and XRP ETF approvals, market awaits clarity. Strong institutional demand drives CME’s launch of crypto options contracts. In a bold move to broaden its cryptocurrency offerings, CME Group has officially launched options on Solana (SOL) and XRP futures. Available since October 13, 2025, these options will allow traders to hedge and manage exposure to two of the most widely traded digital assets in the market. The new contracts come in both full-size and micro-size formats, with expiration options available daily, monthly, and quarterly, providing flexibility for a diverse range of market participants. This expansion aligns with the rising demand for innovative products in the crypto space. Giovanni Vicioso, CME Group’s Global Head of Cryptocurrency Products, noted that the new options offer increased flexibility for traders, from institutions to active individual investors. The growing liquidity in Solana and XRP futures has made the introduction of these options a timely move to meet the needs of an expanding market. Also Read: Vitalik Buterin Reveals Ethereum’s Bold Plan to Stay Quantum-Secure and Simple! Rapid Growth in Solana and XRP Futures Trading CME Group’s decision to roll out options on Solana and XRP futures follows the substantial growth in these futures products. Since the launch of Solana futures in March 2025, more than 540,000 contracts, totaling $22.3 billion in notional value, have been traded. In August 2025, Solana futures set new records, with an average daily volume (ADV) of 9,000 contracts valued at $437.4 million. The average daily open interest (ADOI) hit 12,500 contracts, worth $895 million. Similarly, XRP futures, which launched in May 2025, have seen significant adoption, with over 370,000 contracts traded, totaling $16.2 billion. XRP futures also set records in August 2025, with an ADV of 6,600 contracts valued at $385 million and a record ADOI of 9,300 contracts, worth $942 million. Institutional Demand for Advanced Hedging Tools CME Group’s expansion into options is a direct response to growing institutional interest in sophisticated cryptocurrency products. Roman Makarov from Cumberland Options Trading at DRW highlighted the market demand for more varied crypto products, enabling more advanced risk management strategies. Joshua Lim from FalconX also noted that the new options products meet the increasing need for institutional hedging tools for assets like Solana and XRP, further cementing their role in the digital asset space. The launch of options on Solana and XRP futures marks another step toward the maturation of the cryptocurrency market, providing a broader range of tools for managing digital asset exposure. SEC’s Delay on Solana and XRP ETF Approvals While CME Group expands its offerings, the broader market is also watching the progress of Solana and XRP exchange-traded funds (ETFs). The U.S. Securities and Exchange Commission (SEC) has delayed its decisions on multiple crypto-related ETF filings, including those for Solana and XRP. Despite the delay, analysts anticipate approval may be on the horizon. This week, REX Shares and Osprey Funds are expected to launch an XRP ETF that will hold XRP directly and allocate at least 40% of its assets to other XRP-related ETFs. Despite the delays, some analysts believe that approval could come soon, fueling further interest in these assets. The delay by the SEC has left many crypto investors awaiting clarity, but approval of these ETFs could fuel further momentum in the Solana and XRP futures markets. Also Read: Tether CEO Breaks Silence on $117,000 Bitcoin Price – Market Reacts! The post Breaking: CME Group Unveils Solana and XRP Options appeared first on 36Crypto.
Share
Coinstats2025/09/18 02:35
Why Fintech Platforms Are Growing Faster Than Traditional Banks

Why Fintech Platforms Are Growing Faster Than Traditional Banks

Fintech platforms are outpacing traditional banks in growth across nearly every measurable dimension. Customer acquisition rates, revenue growth, geographic expansion
Share
Techbullion2026/03/24 07:58